Syndax Pharmaceuticals Inc
NASDAQ:SNDX

Watchlist Manager
Syndax Pharmaceuticals Inc Logo
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
Watchlist
Price: 13.08 USD 1.79% Market Closed
Market Cap: 1.1B USD
Have any thoughts about
Syndax Pharmaceuticals Inc?
Write Note

P/OCF
Price to OCF

-4.3
Current
-9.9
Median
21.9
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-4.3
=
Market Cap
1.1B USD
/
Operating Cash Flow
-258.9m USD
All Countries
Close
 
US
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
Average P/OCF: 19.7
Negative Multiple: -4.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -238 967.6
US
Abbvie Inc
NYSE:ABBV
18.8
US
Amgen Inc
NASDAQ:AMGN
19.5
US
Gilead Sciences Inc
NASDAQ:GILD
11.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -121.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -470.8
AU
CSL Ltd
ASX:CSL
30.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -76
NL
argenx SE
XBRU:ARGX
Negative Multiple: -143.8

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More